COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy

Humanitas COVID-19 Task Force

doi:10.1016/j.cgh.2020.05.011

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy

Humanitas COVID-19 Task Force

Istituto Clinico Humanitas

Research output: Contribution to journal › Article › peer-review

Abstract

Since February 2020, the COVID-19 pandemic has spread to Italy affecting more than 100,000 people. Several studies have reported a high prevalence of gastrointestinal (GI) symptoms, and investigated their potential association with clinical outcomes.1 The timing, clinical significance, and possible impact on viral spread of GI symptoms presentation have not been fully elucidated. Elevation of liver function tests and other laboratory values has also been reported; however, their prognostic significance has not been clearly established.2.

Original language	English
Pages (from-to)	2366-2368.e3
Journal	Clinical Gastroenterology and Hepatology
Volume	18
Issue number	10
DOIs	https://doi.org/10.1016/j.cgh.2020.05.011
Publication status	Published - Sep 2020

Keywords

Aged
Betacoronavirus
COVID-19
Coronavirus Infections/complications
Female
Gastrointestinal Diseases/complications
Hospitals/statistics & numerical data
Humans
Italy/epidemiology
Male
Pandemics
Pneumonia, Viral/complications
Prevalence
SARS-CoV-2

Access to Document

10.1016/j.cgh.2020.05.011

Cite this

@article{0ffe69dd824140c48cd3590632ac6baf,

title = "COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy",

abstract = "Since February 2020, the COVID-19 pandemic has spread to Italy affecting more than 100,000 people. Several studies have reported a high prevalence of gastrointestinal (GI) symptoms, and investigated their potential association with clinical outcomes.1 The timing, clinical significance, and possible impact on viral spread of GI symptoms presentation have not been fully elucidated. Elevation of liver function tests and other laboratory values has also been reported; however, their prognostic significance has not been clearly established.2.",

keywords = "Aged, Betacoronavirus, COVID-19, Coronavirus Infections/complications, Female, Gastrointestinal Diseases/complications, Hospitals/statistics & numerical data, Humans, Italy/epidemiology, Male, Pandemics, Pneumonia, Viral/complications, Prevalence, SARS-CoV-2",

author = "{Humanitas COVID-19 Task Force} and Alessio Aghemo and Daniele Piovani and Parigi, {Tommaso Lorenzo} and Enrico Brunetta and Nicola Pugliese and Edoardo Vespa and Omodei, {Paolo Dario} and Paoletta Preatoni and Ana Lleo and Alessandro Repici and Antonio Voza and Maurizio Cecconi and Alberto Malesci and Stefanos Bonovas and Silvio Danese",

note = "Copyright {\textcopyright} 2020. Published by Elsevier Inc.",

year = "2020",

month = sep,

doi = "10.1016/j.cgh.2020.05.011",

language = "English",

volume = "18",

pages = "2366--2368.e3",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "10",

}

TY - JOUR

T1 - COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy

AU - Humanitas COVID-19 Task Force

AU - Aghemo, Alessio

AU - Piovani, Daniele

AU - Parigi, Tommaso Lorenzo

AU - Brunetta, Enrico

AU - Pugliese, Nicola

AU - Vespa, Edoardo

AU - Omodei, Paolo Dario

AU - Preatoni, Paoletta

AU - Lleo, Ana

AU - Repici, Alessandro

AU - Voza, Antonio

AU - Cecconi, Maurizio

AU - Malesci, Alberto

AU - Bonovas, Stefanos

AU - Danese, Silvio

PY - 2020/9

Y1 - 2020/9

N2 - Since February 2020, the COVID-19 pandemic has spread to Italy affecting more than 100,000 people. Several studies have reported a high prevalence of gastrointestinal (GI) symptoms, and investigated their potential association with clinical outcomes.1 The timing, clinical significance, and possible impact on viral spread of GI symptoms presentation have not been fully elucidated. Elevation of liver function tests and other laboratory values has also been reported; however, their prognostic significance has not been clearly established.2.

AB - Since February 2020, the COVID-19 pandemic has spread to Italy affecting more than 100,000 people. Several studies have reported a high prevalence of gastrointestinal (GI) symptoms, and investigated their potential association with clinical outcomes.1 The timing, clinical significance, and possible impact on viral spread of GI symptoms presentation have not been fully elucidated. Elevation of liver function tests and other laboratory values has also been reported; however, their prognostic significance has not been clearly established.2.

KW - Aged

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus Infections/complications

KW - Female

KW - Gastrointestinal Diseases/complications

KW - Hospitals/statistics & numerical data

KW - Humans

KW - Italy/epidemiology

KW - Male

KW - Pandemics

KW - Pneumonia, Viral/complications

KW - Prevalence

KW - SARS-CoV-2

U2 - 10.1016/j.cgh.2020.05.011

DO - 10.1016/j.cgh.2020.05.011

M3 - Article

C2 - 32437870

VL - 18

SP - 2366-2368.e3

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 10

ER -

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy

Abstract

Keywords

Access to Document

Fingerprint

Cite this